Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates

About this update from Innate Pharma Sa Class A

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/7978153931efa12525b2cc1f5dcb36e4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2dbVGaEBCT6PjYH05pz7lQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/7978153931efa12525b2cc1f5dcb36e4","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/UW8lAfZqKUAKXAb8Tp33hQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/7978153931efa12525b2cc1f5dcb36e4","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MARSEILLE, France, November 05, 2025--(BUSINESS WIRE)--Regulatory News:","length":71,"tagName":"p"},{"type":"text","content":"Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Thursday, November 13, 2025, at 2 p.m. CET / 8 a.m. ET, to give an update on business progress during the third quarter of 2025.","length":293,"tagName":"p"},{"type":"text","content":"Participants during the call will be:","length":37,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Jonathan Dickinson, Chief Executive Officer","length":43,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Sonia Quaratino, Executive Vice President, Chief Medical Officer","length":64,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Yannis Morel, Executive Vice President, Chief Operating Officer","length":63,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Stéphanie Cornen, Vice President, Investor Relation, Communication and Commercial Strategy","length":90,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Frédéric Lombard, Senior Vice President, Chief Financial Officer","length":64,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":324,"olType":false},{"type":"text","content":"Details for the Virtual Event","length":29,"tagName":"p"},{"type":"text","content":"The live webcast will be available at the following link: https://events.q4inc.com/attendee/424851735","length":101,"tagName":"p","attribs":{}},{"type":"text","content":"An...

More updates from Innate Pharma Sa Class A